Encompass Health director awarded 85 RSUs from dividend

Encompass Health Corp director Joan E. Herman received an automatic share-based award tied to a dividend payment.

Rhea-AI Filing Summary

Encompass Health Corp director Joan E. Herman received an automatic share-based award tied to a dividend payment. On April 15, 2026, she acquired 85 Encompass Health common stock equivalent restricted stock units at no cash cost, credited under existing RSU agreements in connection with a $0.19 per share dividend and a $105.24 closing price. Following this grant, she directly holds 47,924 shares of Encompass Health common stock.

Insider Trade Summary

Grant/Award: 85 shares

Grant/Award 1 txn

Insider HERMAN JOAN E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	85	$0.00	$0.00

Holdings After Transaction: Encompass Health Common Stock — 47,924 shares (Direct)

Footnotes (1)

1. F1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Key Figures

RSUs awarded: 85 units Dividend per share: $0.19 per share Closing stock price: $105.24 +2 more

5 metrics

RSUs awarded 85 units Restricted stock units credited on April 15, 2026

Dividend per share $0.19 per share Common stock dividend paid April 15, 2026

Closing stock price $105.24 Encompass Health common stock on April 15, 2026

Shares held after transaction 47,924 shares Direct Encompass Health common stock holdings after RSU award

Transaction price per share $0.00 Grant/award acquisition with no cash paid per share

Key Terms

restricted stock unit, non-employee director, dividend record date, dividend payment date, +1 more

5 terms

restricted stock unit financial

"additional restricted stock units ("RSUs") are credited to each non-employee director's account"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

non-employee director financial

"RSUs are credited to each non-employee director's account in connection with common stock dividend payments"

dividend record date financial

"number of the RSUs in each director's account on the associated dividend record date"

dividend payment date financial

"divided by (b) the closing price on the dividend payment date"

grant, award, or other acquisition financial

"transaction code description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Encompass Health (EHC) director Joan E. Herman report?

Director Joan E. Herman reported receiving 85 restricted stock units tied to Encompass Health common stock. The award was an automatic credit under existing RSU agreements connected to a regular dividend payment, rather than an open-market stock purchase or sale.

Why did Joan E. Herman receive 85 RSUs from Encompass Health (EHC)?

She received 85 RSUs because Encompass Health credits additional restricted stock units to non-employee directors when common stock dividends are paid. The number of RSUs is based on RSUs already held, the $0.19 per-share dividend, and the $105.24 closing price on April 15, 2026.

How are Encompass Health (EHC) dividend-related RSUs calculated for directors?

Dividend-related RSUs are calculated by multiplying RSUs already in a director’s account on the dividend record date by the per-share dividend, then dividing by the common stock’s closing price on the dividend payment date. This formula determined Joan Herman’s 85 additional RSUs on April 15, 2026.

What dividend and share price did Encompass Health (EHC) use for this RSU award?

Encompass Health used a cash dividend of $0.19 per common share and a closing stock price of $105.24 on April 15, 2026. These figures are inputs to the formula that credits additional restricted stock units to non-employee directors’ accounts.

How many Encompass Health (EHC) shares does Joan E. Herman hold after this transaction?

After the RSU-related acquisition, Joan E. Herman directly holds 47,924 shares of Encompass Health common stock. This total reflects her position following the crediting of 85 additional restricted stock units associated with the April 15, 2026 dividend payment.

Was Joan E. Herman’s Encompass Health (EHC) Form 4 transaction a market buy or sell?

No, the Form 4 does not show a market buy or sell. It reports a grant or award acquisition coded “A,” reflecting 85 restricted stock units credited automatically under non-employee director RSU agreements tied to a dividend, with no cash price per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/16/2026 - 02:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HERMAN JOAN E

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	04/15/2026		A		85(1)	A	$0	47,924	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $105.24. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Joan E. Herman	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)